Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin LeWinter

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
The American Journal of Cardiology|November 21, 2020
Burden of Recurrent Pericarditis on Health-Related Quality of LifeMartin LeWinter, Apostolos Kontzias, David Lin, et al.
Diabetes Care|June 1, 2014
Metabolic syndrome, C-reactive protein, and mortality in U.S. Blacks and Whites: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) studyTakeki Suzuki, Jenifer Voeks, Neil A Zakai, et al.
European Heart Journal Open|March 16, 2026
'Ablate and pace' reduces mortality in heart failure patients with atrial fibrillation: an updated meta-analysisChristian Lewinter, John G F Cleland, Eslem Sögütlü, et al.
Circulation. Heart Failure|March 19, 2015
Effects of sildenafil on ventricular and vascular function in heart failure with preserved ejection fractionBarry A Borlaug, Gregory D Lewis, Steven E McNulty, et al.
Heart (British Cardiac Society)|November 24, 2020
Efficacy and safety of rilonacept for recurrent pericarditis: results from a phase II clinical trialAllan L Klein, David Lin, Paul C Cremer, et al.
Circulation. Heart Failure|August 15, 2023
Left Ventricular Gene Expression in Heart Failure With Preserved Ejection Fraction-Profibrotic and Proinflammatory Pathways and GenesBo Ye, Amy D Bradshaw, Juan E Abrahante, et al.
Circulation. Heart Failure|May 17, 2014
Resting ventricular-vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary studySelma F Mohammed, Barry A Borlaug, Steven McNulty, et al.
Circulation. Heart Failure|October 29, 2013
Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary studyRosita Zakeri, Barry A Borlaug, Steven E McNulty, et al.
Circulation. Heart Failure|May 7, 2017
INDIE-HFpEF (Inorganic Nitrite Delivery to Improve Exercise Capacity in Heart Failure With Preserved Ejection Fraction): Rationale and DesignYogesh N V Reddy, Gregory D Lewis, Sanjiv J Shah, et al.
American Heart Journal|September 1, 2020
RHAPSODY: Rationale for and design of a pivotal Phase 3 trial to assess efficacy and safety of rilonacept, an interleukin-1α and interleukin-1β trap, in patients with recurrent pericarditisAllan L Klein, Massimo Imazio, Antonio Brucato, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
The American Journal of Cardiology|November 21, 2020
Burden of Recurrent Pericarditis on Health-Related Quality of LifeMartin LeWinter, Apostolos Kontzias, David Lin, et al.
Diabetes Care|June 1, 2014
Metabolic syndrome, C-reactive protein, and mortality in U.S. Blacks and Whites: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) studyTakeki Suzuki, Jenifer Voeks, Neil A Zakai, et al.
European Heart Journal Open|March 16, 2026
'Ablate and pace' reduces mortality in heart failure patients with atrial fibrillation: an updated meta-analysisChristian Lewinter, John G F Cleland, Eslem Sögütlü, et al.
Circulation. Heart Failure|March 19, 2015
Effects of sildenafil on ventricular and vascular function in heart failure with preserved ejection fractionBarry A Borlaug, Gregory D Lewis, Steven E McNulty, et al.
Heart (British Cardiac Society)|November 24, 2020
Efficacy and safety of rilonacept for recurrent pericarditis: results from a phase II clinical trialAllan L Klein, David Lin, Paul C Cremer, et al.
Circulation. Heart Failure|August 15, 2023
Left Ventricular Gene Expression in Heart Failure With Preserved Ejection Fraction-Profibrotic and Proinflammatory Pathways and GenesBo Ye, Amy D Bradshaw, Juan E Abrahante, et al.
Circulation. Heart Failure|May 17, 2014
Resting ventricular-vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary studySelma F Mohammed, Barry A Borlaug, Steven McNulty, et al.
Circulation. Heart Failure|October 29, 2013
Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary studyRosita Zakeri, Barry A Borlaug, Steven E McNulty, et al.
Circulation. Heart Failure|May 7, 2017
INDIE-HFpEF (Inorganic Nitrite Delivery to Improve Exercise Capacity in Heart Failure With Preserved Ejection Fraction): Rationale and DesignYogesh N V Reddy, Gregory D Lewis, Sanjiv J Shah, et al.
American Heart Journal|September 1, 2020
RHAPSODY: Rationale for and design of a pivotal Phase 3 trial to assess efficacy and safety of rilonacept, an interleukin-1α and interleukin-1β trap, in patients with recurrent pericarditisAllan L Klein, Massimo Imazio, Antonio Brucato, et al.
Pageof 3